Mostrar el registro sencillo

dc.contributor.authorBatista Liz, Joao Carloses_ES
dc.contributor.authorGenre, Fernandaes_ES
dc.contributor.authorPulito Cueto, Verónicaes_ES
dc.contributor.authorRemuzgo Martínez, Saraes_ES
dc.contributor.authorPrieto Peña, Diana es_ES
dc.contributor.authorMárquez, Anaes_ES
dc.contributor.authorOrtego-Centeno, Norbertoes_ES
dc.contributor.authorLeonardo Cabello, María Teresa es_ES
dc.contributor.authorPeñalba Citores, Ana Cristinaes_ES
dc.contributor.authorNarváez, Javieres_ES
dc.contributor.authorMartín Penagos, Luises_ES
dc.contributor.authorBelmar Vega, Laraes_ES
dc.contributor.authorGómez Fernández, Cristinaes_ES
dc.contributor.authorMiranda-Filloy, José A.es_ES
dc.contributor.authorCaminal-Montero, Luises_ES
dc.contributor.authorCollado, Pazes_ES
dc.contributor.authorÁrgila, Diego dees_ES
dc.contributor.authorQuiroga-Colina, Patriciaes_ES
dc.contributor.authorVicente-Rabaneda, Esther F.es_ES
dc.contributor.authorTriguero-Martínez, Anaes_ES
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-02-24T15:16:11Z
dc.date.available2023-02-24T15:16:11Z
dc.date.issued2022es_ES
dc.identifier.issn2077-0383es_ES
dc.identifier.otherPI18/00042; PI21/00042es_ES
dc.identifier.urihttps://hdl.handle.net/10902/27884
dc.description.abstractCD40, BLK and BANK1 genes involved in the development and signaling of B-cells are identified as susceptibility loci for numerous inflammatory diseases. Accordingly, we assessed the potential influence of CD40, BLK and BANK1 on the pathogenesis of immunoglobulin-A vasculitis (IgAV), predominantly a B-lymphocyte inflammatory condition. Three genetic variants within CD40 (rs1883832, rs1535045, rs4813003) and BLK (rs2254546, rs2736340, rs2618476) as well as two BANK1 polymorphisms (rs10516487, rs3733197), previously associated with inflammatory diseases, were genotyped in 382 Caucasian patients with IgAV and 955 sex- and ethnically matched healthy controls. No statistically significant differences were observed in the genotype and allele frequencies of CD40, BLK and BANK1 when IgAV patients and healthy controls were compared. Similar results were found when CD40, BLK and BANK1 genotypes or alleles frequencies were compared between patients with IgAV stratified according to the age at disease onset or to the presence/absence of gastrointestinal or renal manifestations. Moreover, no CD40, BLK and BANK1 haplotype differences were disclosed between patients with IgAV and healthy controls and between patients with IgAV stratified according to the clinical characteristics mentioned above. Our findings indicate that CD40, BLK and BANK1 do not contribute to the genetic background of IgAV.es_ES
dc.description.sponsorshipFunding: This study was supported by European Union FEDER funds and “Fondo de Investigaciones Sanitarias” (grants PI18/00042 and PI21/00042) from “Instituto de Salud Carlos III” (ISCIII, Health Ministry, Spain). D.P.-P. is a recipient of a Río Hortega program fellowship from the ISCIII, co-funded by the European Social Fund (ESF, “Investing in your future”) (grant number CM20/00006). F.G. is supported by funds of the RICORS Program from ISCIII, co-funded by the European Union (grant number RD21/0002/0025). V.P.-C. is supported by funds of PI18/00042. S.R.-M. is supported by funds of the RETICS Program (RD16/0012/0009) (ISCIII, co-funded by the European Regional Development Fund (ERDF)). O.G. is a staff member of Xunta de Galicia (Servizo Galego de Saude (SERGAS)) through a research-staff stabilization contract (ISCIII/SERGAS) and his work is funded by ISCIII and the European Union FEDER fund (grant numbers RD16/0012/0014 (RIER) and PI17/00409). He is a beneficiary of project funds from the Research Executive Agency (REA) of the European Union in the framework of MSCA-RISE Action of the H2020 Program, project 734899—Olive-Net. R.L.-M. is a recipient of a Miguel Servet type II program fellowship from the ISCIII, co-funded by ESF (“Investing in your future”) (grant number CPII21/00004). Acknowledgments: We are indebted to the patients and healthy controls for their essential collaboration on this study. We also thank the National DNA Bank Repository (Salamanca) for supplying part of the control samples.es_ES
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)es_ES
dc.rightsAttribution 4.0 International*
dc.rights© 2022 by the authors. Licensee MDPI, Basel, Switzerland.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJournal of Clinical Medicine 2022, 11, 5577es_ES
dc.subject.otherBANK1es_ES
dc.subject.otherBLKes_ES
dc.subject.otherCD40es_ES
dc.subject.otherHenoch–Schönlein purpuraes_ES
dc.subject.otherIgA vasculitises_ES
dc.subject.otherPolymorphismses_ES
dc.titleIgA vasculitis: influence of CD40, BLK and BANK1 gene polymorphismses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/jcm11195577es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/jcm11195577es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International